BridgeBio Oncology Therapeutics, Inc.
What this means
- Net loss in 2025Net loss of $134M for the year (2024: −$74.3M).
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Net income (loss) | −$134M | −$74.3M |
| Total assets | $448M | $164M |
| Total liabilities | $37.3M | $19.6M |
| Stockholders’ equity | $411M | −$179M |
| Cash and equivalents | $374M | $30.9M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- BridgeBio Oncology Therapeutics, Inc.
Formerly: Helix Acquisition Corp. II - CIK
- 0001869105
- Tickers
- BBOT
- Kind of filer
- SEC-reporting company
Emerging growth company - Status
- Filing with the SEC
- State of incorporation
- Delaware
- Business address
- South San Francisco, California
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 10, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 10-Q · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
- Form 8-K · items 2.02, 9.01 · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
- Form 8-K · items 5.02 · filed Nov 5, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 11, 2026 · filing
- Form 10-Q · filed Aug 11, 2026 · filing
- Form 8-K · items 5.02, 5.07 · filed Jun 22, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed May 12, 2026 · filing
- Form 10-Q · filed May 12, 2026 · filing
- Form 8-K · items 5.02 · filed Apr 29, 2026 · filing
- Form 8-K · items 5.02, 7.01, 9.01 · filed Apr 23, 2026 · filing
- Form 8-K · items 5.02 · filed Mar 26, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 5, 2026 · filing
- Form 10-K · filed Mar 5, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 12, 2025 · filing
- Form 10-Q · filed Nov 12, 2025 · filing
- Form S-1 · filed Aug 29, 2025 · filing
- Form SCHEDULE 13D · filed Aug 18, 2025 · filing
- Form 8-K · items 1.01, 2.01, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 8.01, 9.01 · filed Aug 13, 2025 · filing
- Form 8-K · items 1.01, 2.01, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 8.01, 9.01 · filed Aug 13, 2025 · filing
- Form 8-K · items 1.01, 2.01, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 8.01, 9.01 · filed Aug 13, 2025 · filing
- Form 8-K · items 1.01, 2.01, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 8.01, 9.01 · filed Aug 13, 2025 · filing
- Form 10-Q · filed Aug 1, 2025 · filing
- Form 424B4 · filed Jul 10, 2025 · filing
- Form 10-Q · filed May 15, 2025 · filing
- Form 10-K · filed Mar 11, 2025 · filing
- Form 8-K · items 5.02, 9.01 · filed Feb 10, 2025 · filing
- Form 10-Q · filed Nov 14, 2024 · filing
- Form 10-Q · filed Aug 14, 2024 · filing
- Form 10-Q · filed May 15, 2024 · filing
- Form SC 13D · filed Feb 20, 2024 · filing
- Form 8-K · items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01 · filed Feb 14, 2024 · filing
- Form 424B4 · filed Feb 13, 2024 · filing
- Form S-1 · filed Jan 18, 2024 · filing